Aileron Therapeutics, Inc. (ALRN)
ALRN has a market cap or net worth of $9.28 million. The enterprise value is -$2.81 million.
The last earnings date was Friday, October 13, 2023, after market close.
|Earnings Date||Oct 13, 2023|
ALRN has 4.89 million shares outstanding. The number of shares has decreased by -0.00% in one year.
|Shares Change (YoY)||-0.00%|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||9.03%|
|Owned by Institutions (%)||23.19%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 7.88, with zero debt.
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -91.00% and return on invested capital (ROIC) is -122.25%.
|Return on Equity (ROE)||-91.00%|
|Return on Assets (ROA)||-78.50%|
|Return on Capital (ROIC)||-122.25%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$2.16M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -35.00% in the last 52 weeks. The beta is 2.14, so ALRN's price volatility has been higher than the market average.
|52-Week Price Change||-35.00%|
|50-Day Moving Average||1.47|
|200-Day Moving Average||1.58|
|Relative Strength Index (RSI)||61.10|
|Average Volume (30 Days)||47,331|
Short Selling Information
The latest short interest is 77,224, so 1.58% of the outstanding shares have been sold short.
|Short Previous Month||3,851|
|Short % of Shares Out||1.58%|
|Short % of Float||2.29%|
|Short Ratio (days to cover)||0.74|
|Earnings Per Share (EPS)||-$2.86|
The company has $12.09 million in cash and no debt, giving a net cash position of $12.09 million or $2.48 per share.
|Cash & Cash Equivalents||12.09M|
|Net Cash Per Share||$2.48|
|Equity / Book Value||11.20M|
|Book Value Per Share||2.29|
In the last 12 months, operating cash flow was -$13.83 million and capital expenditures $42,000, giving a free cash flow of -$13.78 million.
|Operating Cash Flow||-13.83M|
|Free Cash Flow||-13.78M|
|FCF Per Share||-$3.04|
Dividends & Yields
ALRN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.
|Last Split Date||Nov 11, 2022|